1994
Lithium Augmentation of Fluvoxamine in Autistic Disorder: A Case Report
EPPERSON C, McDOUGLE C, ANAND A, MAREK G, NAYLOR S, VOLKMAR F, COHEN D, PRICE L. Lithium Augmentation of Fluvoxamine in Autistic Disorder: A Case Report. Journal Of Child And Adolescent Psychopharmacology 1994, 4: 201-207. DOI: 10.1089/cap.1994.4.201.Peer-Reviewed Original ResearchSerotonin uptake inhibitorLithium augmentationUptake inhibitorAutistic disorderMinimal clinical responseSubstantial clinical improvementWeeks of treatmentSingle case reportsSignificant adverse effectsClinical improvementClinical responseClinical evidenceCase reportSerotonin functionFluvoxamineMeaningful improvementsTreatment of autismPatientsMarked reductionRating ScaleAdverse effectsRelative efficacyDisordersWeeksTreatment
1981
High Attrition Rates in Commercial Weight Reduction Programs
Volkmar F, Stunkard A, Woolston J, Bailey R. High Attrition Rates in Commercial Weight Reduction Programs. JAMA Internal Medicine 1981, 141: 426-428. PMID: 7212881, DOI: 10.1001/archinte.1981.00340040022010.Peer-Reviewed Original Research